Enanta Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Enanta Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $20.14. The average 1-year stock price forecast is 46.85% higher than the current stock price, while the lowest is $14 (+2.08%) and the highest is $28 (+104.16%).

Price Target: $20.14 (+46.85%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$14	$20.14	$20	$28
Change	+2.08%	+46.85%	+45.83%	+104.16%

Analyst Ratings

The average analyst rating for Enanta Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	5	5	5	5	5	5
Buy	2	2	1	1	1	1
Hold	1	1	1	1	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	7	7	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brandon Folkes H.C. Wainwright	H.C. Wainwright	Buy Reiterates $20	Buy	Reiterates	$20	+45.83%	Jun 23, 2026
Unknown Analyst Rodman & Renshaw No rating	Rodman & Renshaw	Buy Initiates $20	Buy	Initiates	$20	+45.83%	Mar 26, 2026
Anupam Rama J.P. Morgan	J.P. Morgan	Buy Maintains $19	Buy	Maintains	$19	+38.53%	Mar 3, 2026

Financial Forecast

Revenue This Year

67.69M

from 65.32M

3.62%

from 65.32M

Revenue Next Year

67.86M

from 67.69M

0.25%

from 67.69M

EPS This Year

-1.94

from -3.84

EPS Next Year

-1.96

from -1.94

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Sep 30, 2021	Sep 30, 2022	Sep 30, 2023	Sep 30, 2024	Sep 30, 2025	Sep 30, 2026
Revenue	97.07M	86.16M	79.20M	67.64M	65.32M	67.69M
Revenue Growth	-20.74%	-11.24%	-8.07%	-14.61%	-3.42%	3.62%
Gross Profit	97.07M	86.16M	79.20M	67.64M	65.32M	67.69M
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Income	-109.57M	-123.84M	-137.21M	-121.69M	-85.35M	-70.05M
Net Income	-79.00M	-121.76M	-133.82M	-116.05M	-81.89M	-60.18M
EPS	-	-	-	-	-3.84	-1.94
Free Cash Flow	-57.67M	-42.08M	-62.34M	-71.38M	-18.54M	-42.00M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	73.1M
Avg	67.7M
Low	61.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	11.9%
Avg	3.6%
Low	-6.6%

EPS Forecast

EPS	2026	2027	2028
High	-1.39
Avg	-1.94
Low	-2.27

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-